RGD Peptide–Albumin Conjugate for Endothelization of Electrospun Materials


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

To improve the endothelization of 3D matrices produced by electrospinning we propose adding cyclo(RGDfC) peptide conjugated to human serum albumin (HSA) (HSA-c(RGDfC)) to the electrospinning solution. HSA-c(RGDfC) has been prepared using a bifunctional linker with N-hydroxysuccinimide and maleimide groups, and the product has been confirmed by 1Н NMR spectroscopy. Electrospun matrices have been fabricated from the solutions of 3% polyurethane Tecoflex EG-80A with 10% HSA and 0.01–1.3% HSA–c(RGDfC) (relative to Tec) in 1,1,1,3,3,3-hexafluoro-2-propanol. The presence of HSA and the cyclo(RGDfC) peptide on the surface of electrospun matrices has been confirmed by FTIR spectroscopy. The structure of matrices has been examined by scanning electron microscopy. The ability of the matrices to facilitate the adhesion of primary human umbilical vein endotheliocytes (HUVECs) has been studied. The presence of HSA–c(RGDfC) conjugate in the matrices enhanced cellular adhesion in a dose dependent manner with a maximum effect at 1% HSA-c(RGDfC).

Sobre autores

A. Cherepanova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630055

D. Akisheva

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090

T. Popova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630090

B. Chelobanov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630090

Yu. Chesalov

Boreskov Institute of Catalysis, Federal Research Center, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090

T. Godovikova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630090

A. Karpenko

Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630055

P. Laktionov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630055

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2019